| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/06/2002 | WO2002068698A2 Use of nucleic acid libraries to create toxicological profiles |
| 09/06/2002 | WO2002068694A1 Differentially methylated sequences in pancreatic cancer |
| 09/06/2002 | WO2002068693A2 Method for the systematic discovery of genes and genes discovered thereby |
| 09/06/2002 | WO2002068692A1 Methods for improving or altering promoter/enhancer properties |
| 09/06/2002 | WO2002068690A1 Antisense modulation of wrn expression |
| 09/06/2002 | WO2002068688A1 Antisense modulation of calreticulin expression |
| 09/06/2002 | WO2002068687A2 Function and application of tob gene in central nervous system of mammal |
| 09/06/2002 | WO2002068686A1 Methods for analysis of rna |
| 09/06/2002 | WO2002068685A2 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 09/06/2002 | WO2002068683A2 Circular probe amplification (cpa) using energy-transfer primers |
| 09/06/2002 | WO2002068682A2 Method for identifying biologically active structures of microbial pathogens |
| 09/06/2002 | WO2002068680A2 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068676A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 09/06/2002 | WO2002068672A2 Antisense modulation of recql4 expression |
| 09/06/2002 | WO2002068670A1 A method for transfer of dna segments |
| 09/06/2002 | WO2002068669A2 Matrix attachment regions containing episomal vectors for use in cell-specific gene expression |
| 09/06/2002 | WO2002068668A2 Compositions and methods for production cell culture |
| 09/06/2002 | WO2002068667A2 Regulatory elements from rp1 gene and uses thereof |
| 09/06/2002 | WO2002068666A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
| 09/06/2002 | WO2002068665A2 Constitutive promoter from arabidopsis |
| 09/06/2002 | WO2002068664A1 Recombinant viral switches for the control of gene expression in plants |
| 09/06/2002 | WO2002068663A1 Tau-opathy model |
| 09/06/2002 | WO2002068662A1 Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method |
| 09/06/2002 | WO2002068661A1 FUSED PROTEIN HAVING β1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE II ACTIVITY AND PROCESS FOR PRODUCING THE SAME |
| 09/06/2002 | WO2002068660A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | WO2002068659A1 Agarase and gene thereof |
| 09/06/2002 | WO2002068657A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/06/2002 | WO2002068656A1 Nucleic acids coding for a protein interacting with a porin channel |
| 09/06/2002 | WO2002068655A1 Method of searching for remedy for hepatitis d |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | WO2002068653A2 Tri-hybrid melanoma antigen |
| 09/06/2002 | WO2002068652A2 Nov-x proteins and nucleic acids encoding same |
| 09/06/2002 | WO2002068651A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 09/06/2002 | WO2002068650A2 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | WO2002068649A2 Proteins and nucleic acids encoding same |
| 09/06/2002 | WO2002068648A2 Isolated human ras-like proteins, nucleic acid molecules encoding these humans ras-like proteins, and uses thereof |
| 09/06/2002 | WO2002068647A2 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | WO2002068646A2 Mammalian cytokines; receptors; related reagents and methods |
| 09/06/2002 | WO2002068645A2 Compositions and methods relating to breast specific genes and proteins |
| 09/06/2002 | WO2002068644A1 Promoter of s-adenosyl-l-methionine: jasmonic acid carboxyl methyl transferase gene and method for producing target protein in plants using the same |
| 09/06/2002 | WO2002068643A1 Nomuraeae rileyi-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068641A1 THE INFLAMMATORY INHIBITION FACTOR Fwa116 |
| 09/06/2002 | WO2002068640A1 CELL PROLIFERATION FACTOR Fwa267 |
| 09/06/2002 | WO2002068639A1 CELL PROLIFERATION FACTOR Fwap10576 |
| 09/06/2002 | WO2002068637A2 Nucleic acid-based treatment of diseases or conditions related to west nile virus infection |
| 09/06/2002 | WO2002068636A1 Methods and agents for modifying human angiogenesis |
| 09/06/2002 | WO2002068635A2 Methods of inhibiting expression of a target gene in mammalian cells |
| 09/06/2002 | WO2002068634A2 Method for producing gene libraries |
| 09/06/2002 | WO2002068631A2 Plasmid for insertional mutagenesis in bacteria |
| 09/06/2002 | WO2002068630A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | WO2002068629A2 Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same |
| 09/06/2002 | WO2002068627A2 Vector constucts |
| 09/06/2002 | WO2002068625A2 Packaging cell line for lentiviral vectors |
| 09/06/2002 | WO2002068623A2 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | WO2002068621A2 Rax-related protein |
| 09/06/2002 | WO2002068619A2 Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use |
| 09/06/2002 | WO2002068617A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | WO2002068614A2 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | WO2002068613A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | WO2002068611A1 Method and system of disposing food wastes |
| 09/06/2002 | WO2002068607A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 09/06/2002 | WO2002068606A2 Methods for the identification of herbicides and the modulation of plant growth |
| 09/06/2002 | WO2002068605A2 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | WO2002068603A2 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | WO2002068602A2 Methods for modulating g2a receptor activity |
| 09/06/2002 | WO2002068600A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | WO2002068598A2 Novel selectable marker in plants and other organisms |
| 09/06/2002 | WO2002068597A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068590A2 Antisense modulation of recql expression |
| 09/06/2002 | WO2002068589A2 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | WO2002068587A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3 |
| 09/06/2002 | WO2002068585A2 Tip39 polypeptides |
| 09/06/2002 | WO2002068584A2 Antisense modulation of cytohesin-1 expression |
| 09/06/2002 | WO2002068583A2 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | WO2002068582A2 Phosphorothioate (p=s) oligonucleotides containing modified nucleotides with six-membered azasugars and use for aids therapy thereof |
| 09/06/2002 | WO2002068473A1 Biosensor for detecting chemical agents |
| 09/06/2002 | WO2002068472A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | WO2002068471A2 Nucleic acid molecules and polypeptides for a human cation channel polypeptide |
| 09/06/2002 | WO2002068470A2 Interferon-alpha induced gene |
| 09/06/2002 | WO2002068469A2 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | WO2002068468A2 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | WO2002068467A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | WO2002068466A2 Hypoxia-regulated genes |
| 09/06/2002 | WO2002068464A2 Fusion protein for blocking the hiv nef protein |
| 09/06/2002 | WO2002068463A1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
| 09/06/2002 | WO2002068462A2 Internal standard for electrophoretic and chromatographic separation processes |
| 09/06/2002 | WO2002068461A2 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | WO2002068460A1 Peptide tag for monitoring and purification of proteins |
| 09/06/2002 | WO2002068459A2 Non aggregating fluorescent proteins and methods for using the same |
| 09/06/2002 | WO2002068458A2 Disintegrin homolog, zsnk16 |
| 09/06/2002 | WO2002068454A2 Proteins in a porous support |
| 09/06/2002 | WO2002068453A2 Methods and compositions for the construction and use of fusion libraries using computational protein design methods |
| 09/06/2002 | WO2002068447A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | WO2002068446A1 Antisense modulation of talin expression |
| 09/06/2002 | WO2002068445A1 Antisense nucleic acid inhibitors of mycothiol production in mycobacterium tuberculosis |
| 09/06/2002 | WO2002068444A1 Ttk in diagnosis and as a therapeutic target in cancer |
| 09/06/2002 | WO2002068436A1 Avilamycin derivatives |
| 09/06/2002 | WO2002067990A1 Polynucleotide formulation for enhanced intracellular transfer |